Skip to main content

Table 2 CDH1 intron 2 genotype distributions among DGC cases and controls

From: A novel diffuse gastric cancer susceptibility variant in E-cadherin (CDH1) intron 2: A case control study in an Italian population

+14184ΔAGGG cases (n = 134)

+14184ΔAGGG controls (n = 100)

χ2-test

OR (95%CI)*,†

OR (95%CI)*,†

+/+

+/Δ

Δ/Δ

+/+

+/Δ

Δ/Δ

p

Δ/Δ vs +/+

+/Δ vs +/+

128

4

2

96

3

1

0.947

1.50 (0.13–16.78)

1.00 (0.21–4.57)

95.5%

3%

1.5%

97%

1.5%

1.5%

 

14.2%

2.5%

+14384C>T cases (n = 134)

+14384C>T controls (n = 100)

χ 2 -test

OR (95%CI)

OR (95%CI)

CC

CT

TT

CC

CT

TT

p

TT vs CC

CT vs CC

130

2

2

98

1

1

0.895

1.51 (0.13–16.87)

1.51 (0.13–16.87)

97.0%

1.5%

1.5%

98.0%

1.0%

1.0%

 

12.3%

12.3%

+37235G>A cases (n = 134)

+37235G>A controls (n = 100)

χ 2 -test

OR (95%CI)

OR (95%CI)

GG

GA

AA

GG

GA

AA

p

AA vs GG

GA vs GG

30

56

48

37

50

13

0.0003

4.55 (2.09–9.93)

1.38 (0.75–2.55)

22.4%

41.8%

35.8%

37.0%

50.0%

13.0%

 

100%

40.6%

+37276T>A cases (n = 134)

+37276T>A controls (n = 100)

χ 2 -test

OR (95%CI)

OR (95%CI)

TT

TA

AA

TT

TA

AA

p

AA vs TT

TA vs TT

65

65

4

46

51

3

0.929

0.94 (0.20–4.42)

0.90 (0.53–1.53)

48.5%

48.5%

3.0%

46.0%

51.0%

3.0%

 

1.9%

1.6%

49526C>G cases (n = 134)

+49526C>G controls (n = 100)

χ 2 -test

OR (95%CI)

OR (95%CI)

CC

CG

GG

CC

CG

GG

p

GG vs CC

CG vs GG

34

82

18

30

58

12

0.727

1.32 (0.55–3.19)

1.25 (0.69–2.26)

25.4%

61.2%

13.4%

30.0%

58.0%

12.0%

 

32.2%

22.5%

  1. *OR values are unadjusted.
  2. †The percentage below the OR values estimates the power of association for each variant at the corresponding OR level and assuming a significance level of 5%.